View from City Road: Strange moves from Berkeley
Your support helps us to tell the story
From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or producing our latest documentary, 'The A Word', which shines a light on the American women fighting for reproductive rights, we know how important it is to parse out the facts from the messaging.
At such a critical moment in US history, we need reporters on the ground. Your donation allows us to keep sending journalists to speak to both sides of the story.
The Independent is trusted by Americans across the entire political spectrum. And unlike many other quality news outlets, we choose not to lock Americans out of our reporting and analysis with paywalls. We believe quality journalism should be available to everyone, paid for by those who can afford it.
Your support makes all the difference.THERE is something decidedly odd about the purchase and rapid sale of a 0.7 per cent stake in Higgs & Hill by Berkeley Group.
Berkeley and its directors - including Tony Pidgley, the chief executive - had been buying shares since 1 December and, by the end of last week, the directors owned 200,000, the company 128,000. They were flushed out by a section 212 notice from Higgs, which contacted Berkeley. Higgs says Berkeley 'indicated its intention to add to its stake'. That announcement was issued just before 8am yesterday, sending Higgs' shares up 15p to 58p, adding more than a third to its market value. Four hours later, Berkeley announced that all the shares had been sold. The directors assigned their share of the pounds 40,000 profit to the company.
Berkeley insists that it simply thought the shares were undervalued and bought them as a trade investment. It sold to stop speculation that it was poised to launch a bid - although its shares, up 4p to 318p on the day, hardly moved on the announcement of the stake.
Others believe Berkeley was interested in Higgs' housebuilding business, which would be a logical fit, and Berkeley has signalled its intention to make acquisitions. By selling the shares so quickly, it risks developing a reputation as a share trader, damaging its premium rating. The fact that some of the shares were on the directors' personal account does little to improve the perception.
Higgs & Hill's haste in issuing the section 212 and announcing the stake underlines how vulnerable it feels to a bid. But, in deterring one potential predator it may simply have highlighted its attractions to others.
Its nervousness is understandable. Even after the rise in its shares, they closed yesterday at 49p, less than a third of the expected net asset value at the end of December. Its balance sheet is strong, with gearing only about 10 per cent, and - unlike many of its weaker rivals - it has not been forced to take on unprofitable contracts to keep the cash flowing in.
Consolidation in the sector is necessary, but the risk of taking on loss-making contracts deters most bidders, who prefer to cherry-pick business from the receivers. Higgs & Hill is one of the few attractive targets around. Yesterday's events have hardly helped shore up its defences.
(Photograph omitted)
Join our commenting forum
Join thought-provoking conversations, follow other Independent readers and see their replies
Comments